Dublin, Ireland

Zebunnissa Ramtoola

This inventor holds 6 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Merrion Research III Limited, Merrion Reasearch III Limited, Royal College of Surgeons in Ireland. Active years: 2010-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zebunnissa Ramtoola. Retrieved from https://idiyas.com/inventor/zebunnissa-ramtoola

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 16.7

 

Average Co-Inventor Count = 1.7

ph-index = 6

Forward Citations = 416(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Zebunnissa Ramtoola

Introduction

Zebunnissa Ramtoola is a notable inventor based in Dublin, Ireland. She has made significant contributions to the field of pharmaceuticals and microencapsulation technology. With a total of six patents to her name, her work has advanced the methods of drug delivery and bioavailability enhancement.

Latest Patents

One of her latest patents is a method of producing microcapsules. This method involves providing a core-forming fluid stream and a coating-forming fluid stream. A two spray nozzle arrangement is utilized, with a core nozzle disposed concentrically about a second nozzle. The core-forming fluid stream is sprayed from the core nozzle, while the coating-forming fluid stream is sprayed from the concentric nozzle to produce microcapsules. The microcapsules are solidified upon formation in a suitable gas, with spray drying or spray chilling employed as the means of solidification. Additionally, she has developed a solid oral dosage form containing an enhancer. This dosage form comprises a pharmaceutically active ingredient combined with an enhancer that improves the bioavailability and absorption of the active ingredient. The enhancer is typically a medium chain fatty acid ester, ether, or salt, which is solid at room temperature and has a carbon chain length of 6 to 20 carbon atoms. The solid oral dosage form is preferably a controlled release dosage form, such as a delayed release dosage form.

Career Highlights

Throughout her career, Zebunnissa has worked with various companies, including Merrion Research III Limited. Her innovative approaches have positioned her as a key figure in her field, contributing to advancements in pharmaceutical technologies.

Collaborations

Zebunnissa has collaborated with notable professionals, including her coworker Kenneth Iain Cumming. Their joint efforts have furthered the development of innovative solutions in drug delivery systems.

Conclusion

Zebunnissa Ramtoola's contributions to the field of pharmaceuticals and microencapsulation are noteworthy. Her innovative patents and collaborations highlight her role as a leading inventor in enhancing drug delivery methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…